Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

BioCorRx (BICX) Long-Term Debt Issuances (2016 - 2024)

BioCorRx's Long-Term Debt Issuances history spans 13 years, with the latest figure at $942700.0 for Q3 2025.

  • For Q3 2025, Long-Term Debt Issuances rose 2763.3% year-over-year to $942700.0; the TTM value through Sep 2025 reached $1.7 million, up 266.57%, while the annual FY2024 figure was $931502.0, 55.25% up from the prior year.
  • Long-Term Debt Issuances for Q3 2025 was $942700.0 at BioCorRx, up from -$633100.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $942700.0 in Q3 2025 and bottomed at -$633100.0 in Q2 2025.
  • The 5-year median for Long-Term Debt Issuances is $293273.0 (2023), against an average of $265323.2.
  • The largest YoY upside for Long-Term Debt Issuances was 2763.3% in 2025 against a maximum downside of 1163.75% in 2025.
  • A 5-year view of Long-Term Debt Issuances shows it stood at $300000.0 in 2021, then grew by 18.33% to $355000.0 in 2022, then fell by 27.68% to $256727.0 in 2023, then surged by 184.93% to $731502.0 in 2024, then rose by 28.87% to $942700.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Long-Term Debt Issuances are $942700.0 (Q3 2025), -$633100.0 (Q2 2025), and $633100.0 (Q1 2025).